Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases

Marialuisa Moccia(Institute for Experimental Endocrinology and Oncology), Francesca Carlomagno(CEINGE Biotecnologie Avanzate Franco Salvatore (Italy))
Scientific Reports
August 9, 2021
10.1038/s41598-021-95612-4
Cited by 17

Related Papers

BAY 43-9006 Inhibition of Oncogenic RET Mutants
|JNCI Journal of the National Cancer Institute|2006|471
The Extent of Linkage Disequilibrium in Four Populations with Distinct Demographic Histories
|The American Journal of Human Genetics|2000|182
Sorafenib Inhibits Imatinib-Resistant KIT and Platelet-Derived Growth Factor Receptor β Gatekeeper Mutants
|Clinical Cancer Research|2007|73
Identification of tyrosine 806 as a molecular determinant of RET kinase sensitivity to ZD6474
|Endocrine Related Cancer|2008|40
Ultrasound-induced mechanical damage of cancer cell cytoskeleton causes disruption of nuclear envelope and activation of cGAS-STING
|Scientific Reports|2025|7